SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027702
Filing Date
2023-06-13
Accepted
2023-06-13 16:30:52
Documents
12
Period of Report
2023-06-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K adpt-20230609.htm   iXBRL 8-K 90961
  Complete submission text file 0000950170-23-027702.txt   209745

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adpt-20230609.xsd EX-101.SCH 2490
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adpt-20230609_lab.xml EX-101.LAB 13474
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adpt-20230609_pre.xml EX-101.PRE 9914
6 EXTRACTED XBRL INSTANCE DOCUMENT adpt-20230609_htm.xml XML 4772
Mailing Address 1165 EASTLAKE AVE E SEATTLE WA 98109
Business Address 1165 EASTLAKE AVE E SEATTLE WA 98109 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

IRS No.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38957 | Film No.: 231011608
SIC: 2836 Biological Products, (No Diagnostic Substances)